Ambrx
Los Angeles, CA
Ambrx, Inc. operates as a biopharmaceutical company. The Company develops therapeutics such as long acting proteins, bi-specifics, and antibody drug conjugates. Ambrx operates in worldwide.
ambrx.comCompany Details
Founded
- 2003
Employees
- Between 50 - 200 employees
Raised
- $500,948,992
Headquarters Location
- Los Angeles, CA
Public
- Yes
Acquired
- Yes
CEO
Feng Tian
Founders
- Troy WilsonPeter Schultz
Company Collections
These are collections Ambrx is a part of. Click on the collection name to view similar companies.
Ambrx's Industries
Ambrx Headquarters Location
10975 North Torrey Pines Road, Los Angeles, CA 92037-1051
Total Amount Raised: $500,948,992
Ambrx Funding Rounds
Post Ipo Equity
$75,000,000
Post Ipo Equity
$78,000,000
IPO
Unknown
Private Equity
$200,000,000
Private Equity Investors
Adage Capital ManagementBlackRockInvusFidelityHBM Healthcare InvestmentsCormorant Asset ManagementSuvretta Capital ManagementSeries Unknown
$45,000,000
Series Unknown Investors
Apricot CapitalNortheast SecuritiesSinopharm HoldingHOPU Investment Management CompanyEverbrightHumanwell Healthcare (Group) Co.Fosun PharmaSeries D
$10,000,000
Series D Investors
Versant VenturesMaverick VenturesAravisTavistock Group5am VenturesCMEA CapitalM VenturesSeries C
$52,000,000
Series C Investors
Apposite CapitalTavistock GroupMaverick Ventures5am VenturesVersant VenturesAravisCMEA CapitalRoche Venture FundSeries B
$5,000,000
Series B Investors
Tavistock GroupVersant Ventures5am VenturesSeries A
$23,449,000
Series A Investors
Maverick VenturesTavistock GroupVersant Ventures5am VenturesSeries A
$12,500,000
Series A Investors
Tavistock Group5am Ventures
Funding info provided by Diffbot.
Ambrx Reviews
0 out of 5 stars
Based on 0 reviews
Review data
Share your thoughts
Worked here? Share your experience. Help others decide if this company is right for them. Write a review on Ambrx.